x
Filter:
Filters applied
- Protein Structure and Folding
- MIFRemove MIF filter
Publication Date
Please choose a date range between 2019 and 2021.
Keyword
- cytokine2
- 4-HPP1
- 4-hydroxyphenyl pyruvate1
- allosteric regulation1
- BAL1
- bronchoalveolar lavage1
- CD741
- chemokine1
- chemotaxis1
- cluster of differentiation 741
- D-dopachrome tautomerase1
- DDT1
- HPP1
- hydroxyphenyl pyruvate1
- immunology1
- inflammation1
- inhibition mechanism1
- macrophage1
- macrophage migration inhibitory factor1
- protein conformation1
- tautomerase1
- transverse relaxation-optimized spectroscopy1
- TROSY1
Protein Structure and Folding
2 Results
- Research ArticleOpen Access
A structurally preserved allosteric site in the MIF superfamily affects enzymatic activity and CD74 activation in D-dopachrome tautomerase
Journal of Biological ChemistryVol. 297Issue 3101061Published online: August 8, 2021- Emily Chen
- Krystle Reiss
- Dilip Shah
- Ramu Manjula
- Brandon Allen
- Eva L. Murphy
- and others
Cited in Scopus: 4The macrophage migration inhibitory factor (MIF) family of cytokines contains multiple ligand-binding sites and mediates immunomodulatory processes through an undefined mechanism(s). Previously, we reported a dynamic relay connecting the MIF catalytic site to an allosteric site at its solvent channel. Despite structural and functional similarity, the MIF homolog D-dopachrome tautomerase (also called MIF-2) has low sequence identity (35%), prompting the question of whether this dynamic regulatory network is conserved. - Editors' Pick HighlightsOpen Access
Separating cytokine twins with a small molecule
Journal of Biological ChemistryVol. 294Issue 49p18532–18533Published online: December 6, 2019- Jürgen Bernhagen
Cited in Scopus: 0The cytokine macrophage migration inhibitory factor (MIF) has been characterized as a key immunomodulator and mediator of various diseases. Small molecule inhibitors based on the conserved enzymatic pocket of MIF have been valuable in elucidating MIF mechanisms and developing translational strategies. In contrast, our mechanistic understanding of the MIF homolog MIF-2/d-dopachrome tautomerase (d-DT) and its clinical translation has been hampered, partly because MIF-2–selective inhibitors have been elusive.